Z-Cube is a corporate company of Zambon Company S.p.A. focused on DDT exploitation. (www.ZambonCompany.com).

We invest in and support validation of innovative Drug Delivery Technology concepts, selecting those that show the potential to generate innovative products bringing real benefits to patients in the therapeutic areas of interest for the parent company

What makes Z-Cube unique is our “built rather than buy” strategy. Z-Cube works with the end goal in mind: to move an innovative Drug Delivery Technology through early testing, proof-of concept and technical evaluation together with the development of a new medicine. Z-Cube is able to convert technologies that appear promising in a university laboratory or an early start-up company into a number of commercial opportunities, to generate revenue growth for all parties involved.

All this is delivered through a dedicated Z-Cube Team Member who acts as a personal, single point of contact throughout.

.